Chen Li-Mien, Fan Yang-Guo, Yiang Yia-Tang, Chang Chen-Chu, Lee Wei-Hwa
Division of Hematology/Oncology, Department of Internal Medicine, Armed Forces Taichung General Hospital, Taiping, Taichung, ROC.
J Chin Med Assoc. 2003 Apr;66(4):252-5.
Enteropathy-associated T-cell lymphoma (EATL) is a rare, well-documented complication of celiac disease, accounting for less than 1% of the non-Hodgkin's lymphomas. Perforation as the presentation of intestinal lymphoma is rare, and as the presentation of EATL is even rarer. Herein, we report a 56-year-old female with EATL of the jejunum complicated with intestinal perforation. She was admitted because of sudden onset of severe abdominal pain. Emergent exploratory laparatomy was done under the impression of perforative peptic ulcer, however, an ulcerative tumor with perforation was noted unexpectedly at the proximal jejunum. After tumor resection and end-to-end anastomosis of the jejunum, the patient received eight courses of CHOP (cyclophosphamide, adriamycin, oncovin and prednisolone) chemotherapy. Now she has been disease-free for one and half years after the diagnosis. From our experience and that of others, we consider that combination chemotherapy should be helpful for patients with EATL.
肠病相关T细胞淋巴瘤(EATL)是乳糜泻一种罕见但有充分文献记载的并发症,占非霍奇金淋巴瘤的比例不到1%。肠道淋巴瘤以穿孔为表现很罕见,而EATL以穿孔为表现则更为罕见。在此,我们报告一名56岁女性,患有空肠EATL并伴有肠穿孔。她因突发剧烈腹痛入院。在诊断为穿孔性消化性溃疡的情况下进行了急诊剖腹探查术,然而,在空肠近端意外发现了一个伴有穿孔的溃疡性肿瘤。在肿瘤切除及空肠端端吻合术后,患者接受了8个疗程的CHOP(环磷酰胺、阿霉素、长春新碱和泼尼松龙)化疗。自诊断以来,她目前已无病生存一年半。根据我们及他人的经验,我们认为联合化疗对EATL患者可能有益。